RHOA and carcinoma: Conversely, CB1 receptors also inhibit carcinoma cell migration [46] by reducing RhoA activity, indicating that the differential CB1 receptor-modulation of RhoA signaling may depend on factors such as the cell type and the pathophysiological context.